Literature DB >> 12568304

Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behçet disease.

Kazumi Yamato1.   

Abstract

A 10-year-old girl who had been treated as an outpatient for neurofibromatosis type 1 was admitted with fever, 10% weight loss, and abdominal pain that had persisted for 1 month. The clinical manifestations and the results of endoscopy led to the diagnosis of intestinal Behçet disease. Blood cell dysplasia appeared during the hospitalization. The patient subsequently developed blast cells, and the diagnosis of myelodysplastic syndrome (MDS) was made. Behçet disease was first controlled with steroids and diet followed by chemotherapy and cord blood stem cell transplantation (SCT). Both the MDS and Behçet disease went into remission after transplantation. The use of hematopoietic SCT has the potential not only to cure but also to help explicate the mechanism of Behçet disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12568304     DOI: 10.1007/BF02982607

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  17 in total

Review 1.  Intestinal Behçet's disease: a case report and review of Japanese reports in children.

Authors:  M Tabata; T Tomomasa; H Kaneko; A Morikawa
Journal:  J Pediatr Gastroenterol Nutr       Date:  1999-10       Impact factor: 2.839

Review 2.  Behçet's disease in the Middle East.

Authors:  T Saylan; C Mat; I Fresko; M Melikoğlu
Journal:  Clin Dermatol       Date:  1999 Mar-Apr       Impact factor: 3.541

3.  Concurrent inflammatory bowel disease and myelodysplastic syndromes.

Authors:  G C Harewood; E V Loftus; A Tefferi; W J Tremaine; W J Sandborn
Journal:  Inflamm Bowel Dis       Date:  1999-05       Impact factor: 5.325

Review 4.  Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.

Authors: 
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321

Review 5.  Comparative epidemiology of the rheumatic diseases in children.

Authors:  K Oen
Journal:  Curr Opin Rheumatol       Date:  2000-09       Impact factor: 5.006

Review 6.  Behcet's disease complicated with myelodysplastic syndrome: a report of two cases and review of the literature.

Authors:  K Yano; K Eguchi; K Migita; H Takashima; M Tamura; K Izumino; I Sasagawa; N Sadamori; S Nagataki
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

7.  Myelodysplastic syndrome in childhood: a retrospective study of 189 patients in Japan.

Authors:  H Sasaki; A Manabe; S Kojima; M Tsuchida; Y Hayashi; K Ikuta; I Okamura; K Koike; A Ohara; E Ishii; Y Komada; S Hibi; T Nakahata
Journal:  Leukemia       Date:  2001-11       Impact factor: 11.528

8.  Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies.

Authors:  K Ohnuma; K Isoyama; K Ikuta; Y Toyoda; J Nakamura; F Nakajima; M Tsuchida; M Ohira; A Suminoe; T Hara; H Nishihira
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

Review 9.  Current status of umbilical cord blood hematopoietic stem cell transplantation.

Authors:  E Gluckman
Journal:  Exp Hematol       Date:  2000-11       Impact factor: 3.084

Review 10.  Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry.

Authors:  F Locatelli; M Zecca; C Niemeyer; E Angelucci; G Arcese; C Bender-Gotze; F Bonetti; S Burdach; G Dini; W Ebell; W Friedrich; H Hasle; J Hermann; N Jacobsen; T Klingebiel; B Kremens; G Mann; R Miniero; A Pession; C Peters; P Paolucci; F Rossetti; H J Schmid; J Stary; M Zimmermann
Journal:  Bone Marrow Transplant       Date:  1996-11       Impact factor: 5.483

View more
  7 in total

Review 1.  Immunotherapy of systemic sclerosis.

Authors:  Rebecca Manno; Francesco Boin
Journal:  Immunotherapy       Date:  2010-11       Impact factor: 4.196

Review 2.  Myeloid disorders after autoimmune disease.

Authors:  Prajwal C Boddu; Amer M Zeidan
Journal:  Best Pract Res Clin Haematol       Date:  2019-02-07       Impact factor: 3.020

3.  Pediatric intestinal Behçet disease complicated by myeloid malignancies.

Authors:  Kiichiro Kanamitsu; Akira Shimada; Ritsuo Nishiuchi; Tomonari Shigemura; Yozo Nakazawa; Kenichi Koike; Yuichi Kodama; Yuichi Shinkoda; Yoshifumi Kawano; Kozo Yasui; Koji Sasaki; Ryosuke Kajiwara; Hirokazu Tsukahara; Atsushi Manabe
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

4.  Successful treatment by azacitidine therapy of intestinal Behçet's disease associated with myelodysplastic syndrome.

Authors:  Hiroaki Tanaka; Naomi Shimizu; Emi Tougasaki; Chika Kawajiri; Shinichiro Hashimoto; Yusuke Takeda; Shio Sakai; Masahiro Takeuchi; Chikako Ohwada; Emiko Sakaida; Toshiyuki Takagi; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2013-03-22       Impact factor: 2.490

Review 5.  Updated treatment strategies for intestinal Behçet's disease.

Authors:  Yong Eun Park; Jae Hee Cheon
Journal:  Korean J Intern Med       Date:  2017-12-08       Impact factor: 2.884

6.  Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Yukinori Nakamura; Masafumi Matsuguma; Yoshihiro Tokunaga; Kaoru Yamamoto; Mayumi Tanaka; Yoshinori Tanaka; Toshiaki Yujiri; Yukio Tanizawa
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

7.  Shanghai fever, a fatal enteric illness, in an adult patient with neutropenia caused by treatment-related myelodysplastic syndrome: a case report.

Authors:  Taichi Horino; Tatsunori Miyata; Mitsuhiro Inoue; Kosuke Ono; Asuka Ono; Yoshiyuki Tagayasu; Daichi Nomoto; Takao Mizumoto; Tatsuo Kubota; Nobutomo Miyanari; Hideo Baba
Journal:  Surg Case Rep       Date:  2022-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.